Established and emerging roles peptide YY (PYY) and exploitation in obesity-diabetes
- R. A. Lafferty; P. R. Flatt; N. Irwin Established and emerging roles peptide YY (PYY) and exploitation in obesity-diabetes Curr Opin Endocrinol Diabetes Obes
Insulin Resistance & Diabetes
Chemical cholecystokinin receptor activation protects against obesity-diabetes in high fat fed mice and has sustainable beneficial effects in genetic ob/ob mice
- N. Irwin; I. A. Montgomery; R. C. Moffett; P. R. Flatt Chemical cholecystokinin receptor activation protects against obesity-diabetes in high fat fed mice and has sustainable beneficial effects in genetic ob/ob mice Biochem Pharmacol
Comparison of the independent and combined metabolic effects of subchronic modulation of CCK and GIP receptor action in obesity-related diabetes
- N. Irwin; I. A. Montgomery; F. P. O'Harte; P. Frizelle; P. R. Flatt Comparison of the independent and combined metabolic effects of subchronic modulation of CCK and GIP receptor action in obesity-related diabetes Int J Obes (Lond)
Blockade of gastric inhibitory polypeptide (GIP) action as a novel means of countering insulin resistance in the treatment of obesity-diabetes
- N. Irwin; V. A. Gault; F. P. M. O'Harte; P. R. Flatt Blockade of gastric inhibitory polypeptide (GIP) action as a novel means of countering insulin resistance in the treatment of obesity-diabetes Peptides
Emerging therapeutic potential for xenin and related peptides in obesity and diabetes
- S. L. Craig; V. A. Gault; N. Irwin Emerging therapeutic potential for xenin and related peptides in obesity and diabetes Diabetes Metab Res Rev
Impact of anti-inflammatory nutrients on obesity-associated metabolic-inflammation from childhood through to adulthood
- R. M. Connaughton; A. M. McMorrow; F. C. McGillicuddy; F. E. Lithander; H. M. Roche Impact of anti-inflammatory nutrients on obesity-associated metabolic-inflammation from childhood through to adulthood Proc Nutr Soc
Recent advances in peptide-based therapy for Type 2 diabetes and obesity
- J. M. Conlon; P. R. Flatt; C. J. Bailey Recent advances in peptide-based therapy for Type 2 diabetes and obesity Peptides
Metabolic signature of obesity-associated insulin resistance and type 2 diabetes
- H. Al-Sulaiti; I. Diboun; M. V. Agha; F. F. S. Mohamed; S. Atkin; A. S. Dömling; M. A. Elrayess; N. A. Mazloum Metabolic signature of obesity-associated insulin resistance and type 2 diabetes J Transl Med